RNS Number : 5011M
StreaksAI PLC
18 November 2024
 

18 November 2024

 

This announcement contains information which, prior to its disclosure, was inside information as stipulated under Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310 (as amended). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

StreaksAI PLC

 

("StreaksAI" or "the Company")

Interim results

StreaksAI PLC (LSE: STK), a UK-based generative AI platform, announces its unaudited financial results for the six months ended 31 August 2024.

 

For further information please contact:

 

StreaksAI PLC


Mike Edwards Interim CEO

via First Sentinel

+44 20 3855 5551

Corporate Broker


Brian Stockbridge (First Sentinel)

+44 20 3855 5551

 

About Streaks:

StreaksAI PLC is a provider of AI based conversational technologies. The Company offers two core products in the gaming and conversational AI space.

For more information on the Conversational Gaming AI product, please visit www.playstreaks.com. For more information on the Conversational AI product, please visit www.streaks.ai.

 

 

Chairman's Report

Streaks AI plc is a full stack AI-focused technology company. Having listed in 2023 it has spent the intervening time developing AI technology in the conversational interface space and in the automated bot sector. Both of these developments are nearing completion.

 

As the Large Language AI models have developed, the opportunities to utilise these in applications has widened and we see the penetration of these models and the automated bots that interface with them only increasing.

 

As Streaks AI plc is pre revenue we have made strenuous efforts to minimise discretionary spend in the period so as to extent the operational runway. All continuing Director fees were accrued, unpaid during the period. In doing so, the operational costs incurred in this period are 59% lower than in the same period last year and is expected to be lower again going forward. As such, the Board of the Company are of the opinion that the Company has adequate working capital for the next 12 months. At the end of the period, the Company had cash of £318,000.

 

Michael Edwards

CONDENSED STATEMENT OF COMPREHENSIVE INCOME FOR THE 6 MONTH PERIOD ENDING 31 AUGUST 2024

 

 

 



Unaudited

Unaudited

Audited


Period ending 31 Aug 2024

Period ending 31 Aug 2023

Year ending 29 Feb 2024


Notes

£'000

£'000

£'000

Continuing Operations





Revenue


-

-

1

Cost of Sales


-

-

-

Gross Profit


-

-

1

 

Administrative expenses


 

(383)

 

(925)

 

(1,513)

Write down / impairment


-

-

(63)

Operating loss


(383)

(925)

(1,575)

Finance Income


-

-

-

Finance Costs


-

-

-

Loss before taxation


(383)

(925)

(1,575)

Taxation on loss of ordinary activities


-

-

-

Loss for the year from continuing operations


(383)

(925)

(1,575)

Other comprehensive income


-

-

-

 

Total comprehensive loss for the year attributable to shareholders from continuing operations


 

 

(383)

 

 

(925)

 

 

(1,575)

 

 

Basic & dilutive earnings per share - pence

 

 

4

 

 

(0.10)

 

 

(0.24)

 

 

(0.42)

 

 

 

The notes on page 6-11 form an integral part of the condensed interim financial statements.

CONDENSED STATEMENT OF FINANCIAL POSITION AS AT 31 AUGUST 2024

 

 



Unaudited

Unaudited

Audited



As At 31 Aug 2024

As At 31 Aug 2023

As At 29 Feb 2024


Notes

£'000

£'000

£'000

NON-CURRENT ASSETS





Intangible assets

5

-

63

-

TOTAL NON-CURRENT ASSETS


-

63

-

CURRENT ASSETS





Cash and cash equivalents


318

1,032

565

Trade and other receivables

6

32

79

55

TOTAL CURRENT ASSETS


350

1,111

620

TOTAL ASSETS


350

1,174

620

 

EQUITY





Share capital

8

379

379

379

Share Premium

8

4,880

4,880

4,880

Share Based Payment Reserve

9

704

704

704

Retained Earnings


(5,910)

(4,877)

(5,527)

TOTAL EQUITY


53

1,086

436






CURRENT LIABILITIES





Trade and other payables

7

297

88

184

TOTAL CURRENT LIABILITIES


297

88

184

TOTAL LIABILITIES


297

88

184

TOTAL EQUITY AND LIABILITIES


350

1,174

620

 

 

The notes on page 6-11 form an integral part of the condensed interim financial statements.

 

 

The condensed interim financial statements were approved and authorised by the Board of Directors on 14 November 2024 and were signed on its behalf by:

 

Nicholas Lyth Director

CONDENSED STATEMENT OF CHANGES IN EQUITY FOR THE 6 MONTH PERIOD ENDING 31 AUGUST 2024

 

 


Share Capital

Share Premium

Share based payment reserve

Retained Earnings

Total Equity


£'000

£'000

£'000

£'000

£'000

 

Profit (Loss) for period

 

-

 

-

 

-

 

(925)

 

(925)

Other comprehensive income

0

(0)

-

-

-

Total comprehensive income for year

-

-

-

(925)

(925)

Transactions with owners in own capacity:






Ordinary shares issued

-

-

-

-

-

Share issue costs

-

-

-

-

-

Total transactions with owners in own capacity

-

-

-

-

-

Balance at 31 August 2023

379

4,880

704

(4,876)

1,087

 

Profit (Loss) for period

 

-

 

-

 

-

 

(651)

 

(651)

Other comprehensive income

-

-

-

-

-

Total comprehensive income for year

-

-

-

(651)

(651)

Transactions with owners in own capacity:






Ordinary shares issued

-

-

-

-

-

Share issue costs

-

-

-

-

-

Total transactions with owners in own capacity

-

-

-

-

-

Balance at 29 February 2024

379

4,880

704

(5,527)

436

 

Profit (Loss) for period

 

-

 

-

 

-

 

(383)

 

(383)

Other comprehensive income

-

-

-

-

-

Total comprehensive income for year

-

-

-

(383)

(383)

Transactions with owners in own capacity:






Ordinary shares issued

-

-

-

-

-

Share issue costs

-

-

-

-

-

Total transactions with owners in own capacity

-

-

-

-

-

Balance at 31 August 2024

379

4,880

704

(5,910)

53

CONDENSED STATEMENT OF CASHFLOWS

FOR THE 6 MONTH PERIOD ENDING 31 AUGUST 2024

 

 


Unaudited

Unaudited

Audited

6 month period

ended 31 Aug 2024

6 month period ended 31 Aug 2023

12 month period

ended 29 Feb 2024


£'000

£'000

£'000

Cash flow from operating activities




Loss for the financial year

(383)

(925)

(1,576)

Adjustments for:




Write down / Impairment

-

-

63

Services settled by issue of warrants

-

-

-

Changes in working capital:




Decrease / (Increase) in trade and other receivables

23

117

141

Increase / (decrease) in trade and other payables

113

(229)

(133)

Net cash used in operating activities

(247)

(1,037)

(1,505)





Cash flows from investing activities




Purchase of property, plant and equipment

-

-

-

Purchase of intangible assets

-

-

-

Net cash flow from investing activities

-

-

-





Cash flows from financing activities




Share issue, net of issue costs

-

-

-

Net cash flow from financing activities

-

-

-





Net (decrease) in cash and cash equivalents

(247)

(1,037)

(1,505)

Cash and cash equivalents at beginning of the period

565

2,070

2,070

Foreign exchange impact on cash

-

-

-

Cash and cash equivalents at end of the period

318

1,032

565

NOTES TO THE CONDENSED FINANCIAL STATEMENTS FOR THE 6 MONTH PERIOD ENDING 31 AUGUST 2024

 

1              General information

StreaksAI Plc is a public limited company incorporated in England and Wales and domiciled in the United Kingdom. The registered office and principal place of business is 9th Floor, 16 Great Queen Street, London WC2B 5DG. The Company was incorporated on 19 March 2021.

 

The Company's principal activity is that of a global AI-focused software development company, led by a team experienced in this sector and in the development of technology businesses. It is based in UK and its shares are listed on the main market of the London Stock Exchange (ticker:STK).

 

2              Accounting policies

 

IAS 8 requires that management shall use its judgement in developing and applying accounting policies that result in information which is relevant to the economic decision-making needs of users, that are reliable, free from bias, prudent, complete and represent faithfully the financial position, financial performance and cash flows of the entity.

 

2.1          Basis of preparation

 

The condensed interim financial statements ("interim financial statements") have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" (IAS 34) as adopted by the European Union (EU). The interim financial statements have been prepared on the historical cost basis, except for assets and liabilities measured at fair value through profit and loss, and are presented in pounds sterling (£). All amounts have been rounded to the nearest £'000, unless otherwise stated.

 

The interim financial statements have not been audited. The interim financial statements do not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006. The figures have been prepared using applicable accounting policies and practices consistent with those adopted in the audited annual financial statements ("annual financial statements") for the year ended 29th February 2024.

 

The interim financial statements are for the six months to 31 August 2024, being six months from the financial year end for the Company being 29 February 2024. The interim financial statements do not include all the information and disclosures required in the annual financial statements and should be read in conjunction with the Company's annual financial statements for the period ended 29 February 2024. The Company has disclosed comparative data for the period from 1st March 23 to 31 Aug 2023 as required for disclosure by accounting standards as well as audited figures from the annual financial statements.

 

The functional currency for the Company is determined as the currency of the primary economic environment in which it operates. Both the function and presentational currency of the Company Pounds Sterling (£).

 

The business is not considered to be seasonal in nature.

New standards, amendments and interpretations adopted by the Company

During the current period the Company adopted all the new and revised standards, amendments and interpretations that are relevant to its operations and are effective for accounting periods beginning on 1 December 2023. This adoption did not have a material effect on the accounting policies of the Company.

New standards, amendments and interpretations not yet adopted by the Company

The standards and interpretations that are relevant to the Company, issued, but not yet effective, up to the date of these interim financial statements have been evaluated by the directors and they do not consider that there will be a material impact of transition on the financial statements.

 

2.2          Going concern

 

The Company continues to invest in the development of technology and is prioritising this cost. In light of constrained resources, the Company has taken steps to reduce its cash burn, such as deferring Directors fees and terminating external engagements. As a result, the directors are confident that the Company has sufficient resources to meet its liabilities for a period of at least twelve months from approval of the financial statements and the Directors have therefore adopted the going concern basis of accounting in the preparation of the annual financial statements.

 

 

2.3          Risks and uncertainties

The principal risks and uncertainties relevant to the Company have not changed materially since the release of the annual financial statements for the period ending 28 February 2024. These risks can be referenced in the strategic report contained within the annual financial statements.

 

3             Critical accounting estimates and judgements

 

In the application of the Company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements, are disclosed below:

 

Share Based Payments

The Company measures the cost of equity-settled transactions by reference to the fair value of the equity instruments at the date at which they are granted. The fair value is determined by using the Black-Scholes model taking into account the terms and conditions upon which the instruments were granted. The accounting estimates and assumptions relating to equity-settled share-based payments would have no impact on the carrying amounts of assets and liabilities within the next annual reporting period but may impact profit or loss and equity. There have been no dilutive instruments issued in the period and the value remains equal to that in the annual financial statements as at the last reporting period.

 

4              Earnings per share

 

The basic earnings per share is calculated by dividing the profit/(loss) attributable to equity shareholders by the weighted average number of shares in issue.

 


Unaudited At

31 Aug 2024

Unaudited At

31 Aug 2023

Audited At

29 Feb 2024

Loss for the year from continuing operations

(£'000)

(383)

(925)

(1,575)

Weighted average number of ordinary shares in

issue

378,732,535

378,317,101

378,523,683

Basic and diluted earnings per share for

continuing operations (pence)

(0.10)

(0.24)

(0.42)

 

The Company had in issue 82,700,000 warrants and options at 31 August 2024 (82,700,000 at 31 August 2023). The loss attributable to equity holders and weighted average number of ordinary shares for the purposes of calculating diluted earnings per ordinary share are identical to those used for basic earnings per ordinary share. This is because the exercise of warrants and options would have the effect of reducing the loss per ordinary share and is therefore anti-dilutive.

 

5              Intangible assets

 


Patents

£'000

Cost


At 29 February 2024

-

At 31 August 2024

-

Accumulated amortisation and impairment


At 29 February 2024

-

Charge for the period

-

At 31 August 2024

-

Net book value at 31 August 2024

-

 

 


Patents

£'000

Cost


At 31 August 2023

63

At 29 February 2024

63

Accumulated amortisation and impairment


At 31 August 2023

-

Charge for the period

63*

At 29 February 2024

63

Net book value at 29 February 2024

-

\* The £62,781 Intangible assets in relation to the acquisition of the business from Flatiron Labs Inc were written off following the change in direction of the company, as stated in the Chairman's report in the annual financial statement.

 

 

6              Trade and other receivables

 


Unaudited period

ended 31 Aug

2024

Unaudited period

ended 31 Aug

2024

Audited period

ended 29 Feb

2024


£'000

£'000

£'000

Prepayments

18

79

35

VAT

14

-

20

Total trade & other receivables

32

79

55

 

 

 

 

7              Trade and other payables

 


Unaudited period

ended 31 Aug

2024

Unaudited period

ended 31 Aug

2024

Audited period

ended 29 Feb

2024


£'000

£'000

£'000

Trade creditors

206

44

120

Accruals

91

39

57

Social security and other taxation

-

5

6

Other payables

-

-

1

Total trade & other receivables

297

88

184

 

 

The directors consider that the carrying value of trade and other payables is approximately equal to their fair value.

 

 

 

8              Share capital and share premium

 


Ordinary

Shares

Share

Capital

Share

Premium

Total


#

£

£

£

At 28 February 2024

378,732,535

378,733

4,879,991

5,258,724






At 31 August 2024

378,732,535

378,733

4,879,991

5,258,724

9              Share based payments and other reserves

 

The following warrants over ordinary shares have been granted by the Company and are outstanding at 31 August 2024:

 


Number of Warrants

Exercise Price

Expiry date

On incorporation

-

-

-

Issued on 18 October 2021

26,700,000

£0.01

17 Oct 2024

Issued on 5 January 2023

45,499,000

£0.06

4 Jan 2026

Issued on 5 January 2023

4,501,000

£0.06

4 Jan 2026

Issued on 5 January 2023

6,000,000

£0.03

4 Jan 2026

At 31 Aug 2024

82,700,000



 

There were no dilutive instruments issued in the 6 month period ending 31 August 2024.

 


As at 31 Aug 2024

£

As at 31 Aug 2023

£

As at 28 Feb 2024

£

Share based payments Reserve

703,816

703,816

703,816

Warrants issued in the period

-

-

-

Warrants cancelled in the period

-

-

-

Total

703,816

703,816

703,816

 

 

The fair value of the share warrant rights granted are valued using the Black-Scholes option pricing model. The option pricing model assumptions can be referenced in the annual financial statements.

 

 

 

10           Financial commitments & contingent liabilities

 

There were no capital commitments or contingent liabilities pertaining to the Company at 31 Aug 2024.

 

 

11           Related party transactions

 

The company made payments to the following companies in relation to directors' fees:

 

Period 1 Mar to 31 Aug 2024

£

Period 1 Mar to 31 Aug 2023

£

Year ended 28 Feb 2024

£

Carraway Capital Corp - Mr Mark Rutledge

nil

30,000

48,000

Dark Peak Services Ltd - Mr Nicholas Lyth

nil

18,000

30,000

Marallo Holdings Inc - Mr Michael Edwards

nil

48,000

96,000

Infinity Growth Digital Inc. - Mr David Raphael

41,000

45,000

90,000


41,000

141,000

264,000

12           Events subsequent to period end

There were no material events subsequent to period end that require disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR GPGMAGUPCGQA